MDC1
Basic information
Region (hg38): 6:30699807-30717447
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MDC1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 72 | 11 | 89 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 72 | 14 | 13 |
Variants in MDC1
This is a list of pathogenic ClinVar variants found in the MDC1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-30700586-G-C | not specified | Uncertain significance (May 30, 2024) | ||
6-30700597-G-A | Benign (Aug 14, 2020) | |||
6-30702765-C-T | not specified | Uncertain significance (Jan 25, 2023) | ||
6-30702771-C-T | not specified | Likely benign (Jun 13, 2023) | ||
6-30702787-C-T | not specified | Uncertain significance (Nov 07, 2022) | ||
6-30703174-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
6-30703175-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
6-30703210-G-A | not specified | Likely benign (May 23, 2024) | ||
6-30703222-A-G | not specified | Uncertain significance (Jul 30, 2023) | ||
6-30703429-T-C | Benign (Jun 15, 2018) | |||
6-30703435-C-T | not specified | Uncertain significance (May 21, 2024) | ||
6-30703452-C-T | Benign (Nov 01, 2023) | |||
6-30703467-C-T | not specified | Likely benign (Jun 28, 2022) | ||
6-30703639-C-G | not specified | Uncertain significance (Jun 30, 2022) | ||
6-30703662-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
6-30703749-T-C | not specified | Uncertain significance (Jun 13, 2022) | ||
6-30703751-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
6-30703829-G-A | not specified | Uncertain significance (Sep 21, 2023) | ||
6-30703863-C-T | not specified | Uncertain significance (Jul 26, 2021) | ||
6-30703890-C-T | not specified | Uncertain significance (Mar 20, 2023) | ||
6-30703940-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
6-30703940-G-C | not specified | Uncertain significance (May 13, 2024) | ||
6-30703970-T-A | not specified | Likely benign (Jun 28, 2022) | ||
6-30704051-G-A | Uncertain significance (Jan 12, 2022) | |||
6-30704051-G-T | not specified | Uncertain significance (Feb 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MDC1 | protein_coding | protein_coding | ENST00000376406 | 14 | 18083 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.27e-8 | 1.00 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.79 | 942 | 1.11e+3 | 0.849 | 0.0000568 | 13371 |
Missense in Polyphen | 258 | 332.65 | 0.77559 | 4072 | ||
Synonymous | 2.55 | 361 | 428 | 0.843 | 0.0000218 | 4542 |
Loss of Function | 4.58 | 25 | 64.7 | 0.386 | 0.00000342 | 790 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000218 | 0.000213 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.0000470 | 0.0000462 |
European (Non-Finnish) | 0.000163 | 0.000158 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000165 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Required for checkpoint mediated cell cycle arrest in response to DNA damage within both the S phase and G2/M phases of the cell cycle. May serve as a scaffold for the recruitment of DNA repair and signal transduction proteins to discrete foci of DNA damage marked by 'Ser-139' phosphorylation of histone H2AFX. Also required for downstream events subsequent to the recruitment of these proteins. These include phosphorylation and activation of the ATM, CHEK1 and CHEK2 kinases, and stabilization of TP53 and apoptosis. ATM and CHEK2 may also be activated independently by a parallel pathway mediated by TP53BP1. {ECO:0000269|PubMed:12475977, ECO:0000269|PubMed:12499369, ECO:0000269|PubMed:12551934, ECO:0000269|PubMed:12607003, ECO:0000269|PubMed:12607004, ECO:0000269|PubMed:12607005, ECO:0000269|PubMed:12611903, ECO:0000269|PubMed:14695167, ECO:0000269|PubMed:15201865, ECO:0000269|PubMed:15377652}.;
- Pathway
- TP53 Regulates Transcription of DNA Repair Genes;ATM Signaling Network in Development and Disease;HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;Gene expression (Transcription);Nonhomologous End-Joining (NHEJ);DNA Double-Strand Break Repair;Generic Transcription Pathway;SUMOylation of DNA damage response and repair proteins;Homology Directed Repair;Post-translational protein modification;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;RNA Polymerase II Transcription;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;SUMOylation;TP53 Regulates Transcription of DNA Repair Genes;Transcriptional Regulation by TP53;Cell Cycle;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Processing of DNA double-strand break ends;ATM pathway
(Consensus)
Intolerance Scores
- loftool
- 0.630
- rvis_EVS
- 5.2
- rvis_percentile_EVS
- 99.83
Haploinsufficiency Scores
- pHI
- 0.744
- hipred
- Y
- hipred_score
- 0.519
- ghis
- 0.511
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.951
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mdc1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; immune system phenotype; hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- double-strand break repair via nonhomologous end joining;intra-S DNA damage checkpoint
- Cellular component
- nucleus;nucleoplasm;chromosome;focal adhesion;nuclear body
- Molecular function
- protein binding;protein C-terminus binding;identical protein binding;FHA domain binding